1.
J Wound Care
; 32(Sup4b): S1-S31, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37079485
RESUMO
There are currently over 80 biomaterials derived from autologous, allogeneic, synthetic and xenogeneic sources, or a combination of any or all these types of materials, available for soft-tissue coverage to effect wound closure. Often generically referred to as cellular and/or tissue-based products (CTPs), they are manufactured under various trade names and marketed for a variety of indications.